Aura Biosciences (AURA) Competitors $7.21 -0.28 (-3.74%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$7.20 0.00 (-0.07%) As of 03/3/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends AURA vs. ARQT, KNSA, DYN, SNDX, VIR, NRIX, PRAX, ADPT, DAWN, and ARDXShould you be buying Aura Biosciences stock or one of its competitors? The main competitors of Aura Biosciences include Arcutis Biotherapeutics (ARQT), Kiniksa Pharmaceuticals (KNSA), Dyne Therapeutics (DYN), Syndax Pharmaceuticals (SNDX), Vir Biotechnology (VIR), Nurix Therapeutics (NRIX), Praxis Precision Medicines (PRAX), Adaptive Biotechnologies (ADPT), Day One Biopharmaceuticals (DAWN), and Ardelyx (ARDX). These companies are all part of the "pharmaceutical products" industry. Aura Biosciences vs. Arcutis Biotherapeutics Kiniksa Pharmaceuticals Dyne Therapeutics Syndax Pharmaceuticals Vir Biotechnology Nurix Therapeutics Praxis Precision Medicines Adaptive Biotechnologies Day One Biopharmaceuticals Ardelyx Aura Biosciences (NASDAQ:AURA) and Arcutis Biotherapeutics (NASDAQ:ARQT) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings, valuation and community ranking. Does the MarketBeat Community favor AURA or ARQT? Arcutis Biotherapeutics received 43 more outperform votes than Aura Biosciences when rated by MarketBeat users. Likewise, 66.34% of users gave Arcutis Biotherapeutics an outperform vote while only 63.16% of users gave Aura Biosciences an outperform vote. CompanyUnderperformOutperformAura BiosciencesOutperform Votes2463.16% Underperform Votes1436.84% Arcutis BiotherapeuticsOutperform Votes6766.34% Underperform Votes3433.66% Do insiders and institutionals hold more shares of AURA or ARQT? 96.8% of Aura Biosciences shares are owned by institutional investors. 5.4% of Aura Biosciences shares are owned by insiders. Comparatively, 9.5% of Arcutis Biotherapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has more volatility & risk, AURA or ARQT? Aura Biosciences has a beta of 0.29, meaning that its share price is 71% less volatile than the S&P 500. Comparatively, Arcutis Biotherapeutics has a beta of 1.29, meaning that its share price is 29% more volatile than the S&P 500. Is AURA or ARQT more profitable? Aura Biosciences has a net margin of 0.00% compared to Arcutis Biotherapeutics' net margin of -140.97%. Aura Biosciences' return on equity of -41.57% beat Arcutis Biotherapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Aura BiosciencesN/A -41.57% -36.43% Arcutis Biotherapeutics -140.97%-119.11%-45.95% Which has better valuation and earnings, AURA or ARQT? Aura Biosciences has higher earnings, but lower revenue than Arcutis Biotherapeutics. Arcutis Biotherapeutics is trading at a lower price-to-earnings ratio than Aura Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAura BiosciencesN/AN/A-$76.41M-$1.73-4.17Arcutis Biotherapeutics$196.54M7.74-$262.14M-$1.16-11.06 Does the media favor AURA or ARQT? In the previous week, Arcutis Biotherapeutics had 30 more articles in the media than Aura Biosciences. MarketBeat recorded 35 mentions for Arcutis Biotherapeutics and 5 mentions for Aura Biosciences. Aura Biosciences' average media sentiment score of 0.71 beat Arcutis Biotherapeutics' score of 0.50 indicating that Aura Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aura Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Arcutis Biotherapeutics 7 Very Positive mention(s) 4 Positive mention(s) 11 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Positive Do analysts rate AURA or ARQT? Aura Biosciences presently has a consensus price target of $23.00, indicating a potential upside of 219.00%. Arcutis Biotherapeutics has a consensus price target of $18.00, indicating a potential upside of 40.30%. Given Aura Biosciences' stronger consensus rating and higher probable upside, equities research analysts clearly believe Aura Biosciences is more favorable than Arcutis Biotherapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aura Biosciences 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 3.29Arcutis Biotherapeutics 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 SummaryAura Biosciences beats Arcutis Biotherapeutics on 10 of the 17 factors compared between the two stocks. Get Aura Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AURA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AURA vs. The Competition Export to ExcelMetricAura BiosciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$360.15M$3.08B$5.81B$8.40BDividend YieldN/A1.51%4.75%3.98%P/E Ratio-4.1728.6624.9519.25Price / SalesN/A403.87375.55110.22Price / CashN/A168.6838.0534.58Price / Book1.573.487.334.28Net Income-$76.41M-$71.55M$3.18B$247.04M7 Day Performance-0.96%-5.00%-2.87%-3.25%1 Month Performance-9.88%-10.68%-6.77%-6.55%1 Year Performance-19.80%-22.37%12.32%4.01% Aura Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AURAAura Biosciences2.6562 of 5 stars$7.21-3.7%$23.00+219.0%-22.0%$360.15MN/A-4.1750News CoverageARQTArcutis Biotherapeutics3.3937 of 5 stars$12.39-4.8%$16.60+34.0%+9.0%$1.45B$59.61M-6.92150Earnings ReportAnalyst RevisionKNSAKiniksa Pharmaceuticals2.4049 of 5 stars$19.63-1.9%$36.60+86.4%-1.3%$1.42B$270.26M-140.20220Earnings ReportShort Interest ↑DYNDyne Therapeutics3.192 of 5 stars$13.59-3.0%$49.91+267.2%-57.7%$1.38BN/A-3.82100Earnings ReportAnalyst ForecastAnalyst RevisionSNDXSyndax Pharmaceuticals3.6184 of 5 stars$15.67-4.3%$36.20+131.0%-34.7%$1.34B$16M-4.32110Earnings ReportNews CoverageGap UpVIRVir Biotechnology3.7777 of 5 stars$9.47-1.0%$34.83+267.8%-29.5%$1.30B$86.18M-2.42580Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap DownNRIXNurix Therapeutics2.0084 of 5 stars$16.86-0.1%$31.81+88.7%+4.6%$1.28B$54.55M-5.83300News CoveragePositive NewsPRAXPraxis Precision Medicines2.309 of 5 stars$66.71-10.4%$145.20+117.7%-32.3%$1.24B$2.45M-6.48110Earnings ReportAnalyst ForecastNews CoverageADPTAdaptive Biotechnologies3.5748 of 5 stars$8.42+1.8%$9.10+8.1%+101.0%$1.24B$178.96M-7.72790Positive NewsDAWNDay One Biopharmaceuticals2.5667 of 5 stars$12.18-2.0%$35.71+193.2%-52.7%$1.23BN/A-11.8360Earnings ReportAnalyst RevisionARDXArdelyx4.5864 of 5 stars$5.13+1.4%$9.93+93.5%-45.6%$1.22B$251.85M-32.0690 Related Companies and Tools Related Companies Arcutis Biotherapeutics Competitors Kiniksa Pharmaceuticals Competitors Dyne Therapeutics Competitors Syndax Pharmaceuticals Competitors Vir Biotechnology Competitors Nurix Therapeutics Competitors Praxis Precision Medicines Competitors Adaptive Biotechnologies Competitors Day One Biopharmaceuticals Competitors Ardelyx Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AURA) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aura Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aura Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
